MasterCard Inc vs Stryker Corporation — how do they compare? MasterCard Inc trades at $587.31 (market cap $503.50B), while Stryker Corporation trades at $277.34 (market cap $106.24B). The key difference: MasterCard Inc is far larger — about 4.7× Stryker Corporation's market cap, and Stryker Corporation pays the higher dividend (1.27%). Which is the better fit depends on your goals — on Pluang, investors hold MasterCard Inc for 134 Days and Stryker Corporation for 21 Days on average.
| MA | SYK | |
|---|---|---|
Market Cap | $503.50B | $106.24B |
Volume | 3,390,859 | 2,982,001 |
Sector | Financials | Health |
52-Week High | $599.86 | $388.35 |
52-Week Low | $471.55 | $269.75 |
Typical Hold Time | 134 Days | 21 Days |
Enterprise Value | $516.53B | $117.70B |
Dividend Yield | 0.61% | 1.27% |
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $589.14, up 3.35% today, showing strong momentum with consistent earnings beats and bullish technical signals. The stock demonstrates robust fundamentals with 46.34% net margins and 241.49% ROE, supported by growing institutional interest. Recent analyst coverage shows 80% buy ratings with a $666.67 consensus target, indicating significant upside potential from current levels.
Mastercard presents a compelling growth story with expanding global payment volumes and strategic AI investments. Key risks include payment industry disruption from stablecoins and regulatory scrutiny. The company's strong cash flow generation and dividend growth support shareholder returns, though premium valuations require sustained execution.
Stryker (SYK) trades at $277.52, up 0.77% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279. Fundamentally, the company reported strong profitability with a 14.43% net income margin in 2026 and beat EPS estimates in two of the last three quarters. However, recent news highlights potential legal and manufacturing issues that have pressured investor sentiment.
The outlook is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities lie in SYK's robust earnings growth and market leadership in medical technology, but risks include ongoing legal investigations and persistent manufacturing challenges that could impact future performance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →